Novavax appoints senior vp of business development
Russell ‘Rip’ Wilson takes the role at US biopharmaceutical firm
Wilson was most recently chief financial officer at Supernus Pharmaceuticals. He was previously senior vice president, chief financial officer and general counsel of Iomai Corporation, which was acquired in 2008 by Intercell. He was also the acting general counsel of North American Vaccine, until its acquisition by Baxter International in 2000.